Study of sinonasal cancer outcomes and quality of life
Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life
This study looks at how sinonasal cancer affects patients' lives and treatment results to help improve future care for those diagnosed with this type of cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 30 Days to 99 Years |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT04755855 on ClinicalTrials.gov |
What this trial studies
This observational study involves multiple institutions focusing on patients diagnosed with sinonasal carcinoma. It aims to gather data on the progression of sinonasal cancer, treatment outcomes, and the quality of life of affected patients. Additionally, the study will conduct central mutational and genomic analyses of tumor tissues to better understand the disease. By collecting this information, the study seeks to enhance knowledge and improve future treatment strategies for sinonasal cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged between 30 days and 99 years who have been diagnosed with sinonasal cancer and are receiving treatment at the Mayo Clinic.
Not a fit: Patients who are healthy or unwilling to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment approaches and better quality of life for patients with sinonasal cancer.
How similar studies have performed: While this study is focused on sinonasal cancer, similar multi-institutional studies have shown success in understanding cancer outcomes and improving patient care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive) * Patients with a diagnosis of sinonasal cancer * Patients undergoing treatment at Mayo Clinic Exclusion Criteria: * Healthy individuals * Unwilling to sign the informed consent
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Jake Eide, MD — Mayo Clinic
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.